Analytical Data
-
Gene name
HBQ1
- Application
-
Alternative Names
HBQ1;Hemoglobin subunit theta-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P09105
-
Expression Region
1-142aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMALSAED RALVRALWKK LGSNVGVYTT EALERTFLAF PATKTYFSHL DLSPGSSQVR AHGQKVADALSLAVERLDDL PHALSALSHL HACQLRVDPA SFQLLGHCLL VTLARHYPGD FSPALQASLD KFLSHVISAL VSEYR
-
Molecular Weight
18 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HBQ1 is a recombinant protein derived from the human leukocyte antigen (HLA) gene family, particularly associated with immune response modulation. The research into HBQ1 has gained significant attention due to its potential role in various immunological disorders and its implications in vaccine development. With the increasing understanding of the immune system's complexity, scientists are exploring HBQ1's ability to enhance antigen presentation and its influence on T-cell activation. Furthermore, studies have indicated that HBQ1 may interact with various receptors, thereby mediating cellular signaling pathways essential for immune regulation. The advancement of recombinant DNA technology has facilitated the production and characterization of HBQ1, providing a platform for in-depth investigations into its biological functions. Researchers are particularly focused on elucidating its structure-function relationship, which could reveal insights into its mechanisms in disease contexts, including autoimmune disorders and infectious diseases. The potential application of HBQ1 in therapeutic strategies, such as targeted immunotherapy and personalized medicine, underscores the importance of continued research in this area. As the scientific community seeks to harness the capabilities of HBQ1, understanding its biochemical properties and interactions within the immune system could pave the way for innovative treatments and improved health outcomes.
